RNA vaccines train the immune system in a similar way to traditional vaccines, but they use a different strategy to get there ...

CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2024 and Provides Business Update 10.04.2025 / 13:12 CET/CEST The issuer is solely responsible for the content of this ...

Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicine company ...

The global vaccine CDMO market is set to witness a growth rate of 8% in the next 5 years. Increasing demand for vaccines, ...

Researchers from Agency for Science, Technology and Research in Singapore recently published a review article exploring how ...

Concern is growing among public health experts that anti-vaccine sentiment within federal and state governments may derail emerging and cutting-edge vaccines that are now awaiting regulatory approval ...

Spray-drying represents a well-established technique that addresses solubility and other manufacturing and stability challenges.

Discover how an emerging technology called tRNA therapy could become the next big thing in genetic disease treatment.